NCT00078221|UnknownPhase 3
Loading search results
Sponsor study identifier
interventional
180
2 countries
8
Study Start
August 1999
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD. Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins, fats and other substances from the blood, improving blood flow to the macula, potentially improving vision.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 1999
Date type not reportedThis date has not been verified as actual or estimated.
February 20, 2004
Actual (reported)March 1, 2004
Actual (reported)December 2005
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Retina Vitreous Associates
Beverly Hills, California, 90211, United States
Aran Eye Associates
Coral Gables, Florida, 33134, United States
Retina Health Care
Fort Myers, Florida, 33901, United States
UIC Eye Center
Chicago, Illinois, 60612, United States
Macula Care
New York, New York, 10021, United States
Carolina Eye Associates
Southern Pines, North Carolina, 28387, United States
Associated Retinal Consultants
Bala-Cynwyd, Pennsylvania, 19004, United States
Pulido JS; Multicenter Investigation of Rheopheresis for AMD (MIRA-1) Study Group. Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis. Trans Am Ophthalmol Soc. 2002;100:85-106; discussion 106-7.
Irving Siegel, MD
OccuLogix
First Submitted
February 20, 2004
First Posted
March 1, 2004
Study Start
August 1999
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
December 2005
Date type not reportedPhase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
W. Bradley Kates, MD
Oakville, Ontario, L6H 3P1, Canada
This date has not been verified as actual or estimated.
Last Updated
May 9, 2008
Record last verified: 2005-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: